Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.61781 | 25 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.58953 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.59236 | 26 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.51532 | 24 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.53979 | 25 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.65018 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.62818 | 26 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.56788 | 25 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.56267 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.58111 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.57723 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.56122 | 26 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.58219 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.58151 | 25 |